プライマリ・シーグレン症候群の患者における腸内微生物群および排泄物および血代謝物のマルチオミクス特性
Yuanyuan Liu1, Qi Wang2, Yan Zhang1
1Department of Rheumatology, The Second Hospital & Clinical Medical School, Lanzhou University, LanzhouGansu, 730030, China.
Clinical rheumatology
|August 29, 2025
まとめ
この研究では,小児性シェーグレン症候群 (pSS) の患者の腸内微生物群および代謝系に重大な変化がみられ,微生物多様性の減少と代謝経路の変化が確認されました. これらの発見は,PSSの予防と治療戦略の洞察を提供します.
科学分野:
- 微生物群の研究
- メタボロミクス
- 自己免疫疾患の病原性
背景:
- 腸内微生物群と代謝産物が,主性シーグレン症候群 (pSS) の発症と関連している証拠が増えています.
- 以前の研究では,pSS患者の腸内微生物群,微生物群,および血代謝群を同時に分析していなかった.
研究 の 目的:
- pSS患者の腸内微生物群と糞便/プラズマ代謝体を包括的に特徴づける.
- マルチオミクス分析により,pSSの潜在的なバイオマーカーと治療標的を特定する.
主な方法:
- 30人のpSS患者と60人の健康な対照群 (HCs) を採用した.
- 排泄物の遺伝子配列を調べた
- 糞便と血のサンプルで非ターゲットのメタボロミクスを行いました.
主要な成果:
- pSSの患者は微生物の豊富さ,多様性,そしてBifidobacteriumのような有益な細菌の減少を示しました.
- 機会性病原体 (例えば,Escherichia coli,Prevotella copri) は,pSS患者で濃縮された.
- 脂肪酸,アミノ酸,ヘテロサイクリック化合物を含む糞便および血の代謝産物における有意な変化がpSS患者で観察されました.
結論:
- この研究は,中国北西部のpSS患者における腸内微生物群と代謝体の最初の統合分析を提供した.
- 特定されたpSSにおける腸内不活性症と代謝不調は,標的型予防と治療戦略を支えている.
- マイクロバイオームとメタボロームの調節がpSSの管理に役立つ可能性を強調しています.
関連する概念動画
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
01:26Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
287
Sputum studies are a critical part of diagnosing and treating numerous respiratory conditions. These studies involve obtaining sputum samples for analysis to identify pathogenic organisms and assess the presence of abnormal cells indicative of malignant conditions. This lesson will delve into three fundamental sputum studies: Gram Stain, Cytology, and Acid-fast Smear and Culture.
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
287
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
238
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
238
01:30Inflammatory Bowel Disease II: Crohn's Disease
375
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
375
01:17Irritable Bowel Syndrome I: Introduction
369
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
369
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
200
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
200